| A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging L Keren, M Bosse, D Marquez, R Angoshtari, S Jain, S Varma, SR Yang, ... Cell 174 (6), 1373-1387. e19, 2018 | 831 | 2018 |
| Precision medicine in non-small cell lung cancer: Current applications and future directions SR Yang, AM Schultheis, H Yu, D Mandelker, M Ladanyi, R Büttner Seminars in cancer biology 84, 184-198, 2022 | 174 | 2022 |
| Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L) 1 blockade in patients with non-small cell lung cancer RS Vanguri, J Luo, AT Aukerman, JV Egger, CJ Fong, N Horvat, ... Nature cancer 3 (10), 1151-1164, 2022 | 121 | 2022 |
| ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer A Passaro, N Leighl, F Blackhall, S Popat, K Kerr, MJ Ahn, ME Arcila, ... Annals of Oncology 33 (5), 466-487, 2022 | 104 | 2022 |
| Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS A Rose Brannon, G Jayakumaran, M Diosdado, J Patel, A Razumova, ... Nature communications 12 (1), 3770, 2021 | 91 | 2021 |
| A performance comparison of commonly used assays to detect RET fusions SR Yang, U Aypar, EY Rosen, DA Mata, R Benayed, K Mullaney, ... Clinical Cancer Research 27 (5), 1316-1328, 2021 | 63 | 2021 |
| Rare molecular subtypes of lung cancer G Harada, SR Yang, E Cocco, A Drilon Nature Reviews Clinical Oncology 20 (4), 229-249, 2023 | 46 | 2023 |
| Clinicopathologic Features and Response to Therapy of NRG1 Fusion–Driven Lung Cancers: The eNRGy1 Global Multicenter Registry A Drilon, M Duruisseaux, JY Han, M Ito, C Falcon, SR Yang, ... Journal of Clinical Oncology 39 (25), 2791-2802, 2021 | 44 | 2021 |
| Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers NJ Choudhury, A Marra, JSY Sui, J Flynn, SR Yang, CJ Falcon, ... Journal of Thoracic Oncology 18 (4), 463-475, 2023 | 41 | 2023 |
| Molecular characterization of peritoneal mesotheliomas M Offin, SR Yang, J Egger, G Jayakumaran, RS Spencer, J Lopardo, ... Journal of Thoracic Oncology 17 (3), 455-460, 2022 | 40 | 2022 |
| Comprehensive genomic profiling of malignant effusions in patients with metastatic lung adenocarcinoma SR Yang, CY Lin, H Stehr, SR Long, CS Kong, GJ Berry, JL Zehnder, ... The Journal of Molecular Diagnostics 20 (2), 184-194, 2018 | 39 | 2018 |
| Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions DA Mata, JK Benhamida, AL Lin, CM Vanderbilt, SR Yang, LB Villafania, ... Acta neuropathologica communications 8, 1-13, 2020 | 36 | 2020 |
| Ultrarapid EGFR mutation screening followed by comprehensive next-generation sequencing: a feasible, informative approach for lung carcinoma cytology specimens with a high … ME Arcila, SR Yang, A Momeni, DA Mata, P Salazar, R Chan, D Elezovic, ... JTO clinical and research reports 1 (3), 100077, 2020 | 35 | 2020 |
| Invasive mucinous adenocarcinomas with spatially separate lung lesions: analysis of clonal relationship by comparative molecular profiling SR Yang, JC Chang, C Leduc, KS Tan, S Dogan, R Benayed, L Borsu, ... Journal of Thoracic Oncology 16 (7), 1188-1199, 2021 | 30 | 2021 |
| Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers NJ Choudhury, JL Schneider, T Patil, VW Zhu, DA Goldman, SR Yang, ... JTO Clinical and Research Reports 2 (7), 100187, 2021 | 25 | 2021 |
| Clinical experience of cerebrospinal fluid–based liquid biopsy demonstrates superiority of cell-free DNA over cell pellet genomic DNA for molecular profiling TA Bale, SR Yang, JP Solomon, K Nafa, S Middha, J Casanova, ... The Journal of Molecular Diagnostics 23 (6), 742-752, 2021 | 24 | 2021 |
| Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions CY Lin, K Mooney, W Choy, SR Yang, K Barry-Holson, K Horst, I Wapnir, ... Modern Pathology 31 (4), 562-568, 2018 | 22 | 2018 |
| Targeted deep sequencing of cell‐free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology SR Yang, KL Mooney, P Libiran, CD Jones, R Joshi, HD Lau, H Stehr, ... Cancer Cytopathology 128 (1), 43-56, 2020 | 21 | 2020 |
| Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies YR Murciano-Goroff, AM Schram, EY Rosen, H Won, Y Gong, ... Nature Communications 13 (1), 7182, 2022 | 18 | 2022 |
| Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non–Small Cell Lung … R Thummalapalli, E Bernstein, B Herzberg, BT Li, A Iqbal, I Preeshagul, ... JCO Precision Oncology 7, e2300030, 2023 | 17 | 2023 |
